These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
244 related items for PubMed ID: 28747092
21. Multiple endocrine neoplasia type 2 and the RET protooncogene: from bedside to bench to bedside. Machens A, Dralle H. Mol Cell Endocrinol; 2006 Mar 09; 247(1-2):34-40. PubMed ID: 16343738 [Abstract] [Full Text] [Related]
22. Age-related neoplastic risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germ line RET Cys634Trp (TGC>TGG) mutation. Milos IN, Frank-Raue K, Wohllk N, Maia AL, Pusiol E, Patocs A, Robledo M, Biarnes J, Barontini M, Links TP, de Groot JW, Dvorakova S, Peczkowska M, Rybicki LA, Sullivan M, Raue F, Zosin I, Eng C, Neumann HP. Endocr Relat Cancer; 2008 Dec 09; 15(4):1035-41. PubMed ID: 18794325 [Abstract] [Full Text] [Related]
23. High penetrance of pheochromocytoma in multiple endocrine neoplasia 2 caused by germ line RET codon 634 mutation in Japanese patients. Imai T, Uchino S, Okamoto T, Suzuki S, Kosugi S, Kikumori T, Sakurai A, MEN Consortium of Japan. Eur J Endocrinol; 2013 May 09; 168(5):683-7. PubMed ID: 23416954 [Abstract] [Full Text] [Related]
24. Risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germline RET mutations located in exon 10. Frank-Raue K, Rybicki LA, Erlic Z, Schweizer H, Winter A, Milos I, Toledo SP, Toledo RA, Tavares MR, Alevizaki M, Mian C, Siggelkow H, Hüfner M, Wohllk N, Opocher G, Dvořáková S, Bendlova B, Czetwertynska M, Skasko E, Barontini M, Sanso G, Vorländer C, Maia AL, Patocs A, Links TP, de Groot JW, Kerstens MN, Valk GD, Miehle K, Musholt TJ, Biarnes J, Damjanovic S, Muresan M, Wüster C, Fassnacht M, Peczkowska M, Fauth C, Golcher H, Walter MA, Pichl J, Raue F, Eng C, Neumann HP, International RET Exon 10 Consortium. Hum Mutat; 2011 Jan 09; 32(1):51-8. PubMed ID: 20979234 [Abstract] [Full Text] [Related]
25. A Homozygous RET K666N Genotype With an MEN2A Phenotype. Jaber T, Hyde SM, Cote GJ, Grubbs EG, Giles WH, Stevens CA, Dadu R. J Clin Endocrinol Metab; 2018 Apr 01; 103(4):1269-1272. PubMed ID: 29408964 [Abstract] [Full Text] [Related]
26. [C634R mutation of the protooncongene RET and molecular diagnosis in multiple endocrine neoplasia type 2 in a large Moroccan family]. Benazzouz B, Hafidi A, Benkhira S, Chraibi A, Kadiri A, Hilal L. Bull Cancer; 2008 Apr 01; 95(4):457-63. PubMed ID: 18495576 [Abstract] [Full Text] [Related]
27. Multiple endocrine neoplasia 2A due to a unique C609S RET mutation presents with pheochromocytoma and reduced penetrance of medullary thyroid carcinoma. Kinlaw WB, Scott SM, Maue RA, Memoli VA, Harris RD, Daniels GH, Porter DM, Belloni DR, Spooner ET, Ernesti MM, Noll WW. Clin Endocrinol (Oxf); 2005 Dec 01; 63(6):676-82. PubMed ID: 16343103 [Abstract] [Full Text] [Related]
28. Composite phaeochromocytoma-ganglioneuroblastoma in a patient with multiple endocrine neoplasia type IIA. Matias-Guiu X, Garrastazu MT. Histopathology; 1998 Mar 01; 32(3):281-2. PubMed ID: 9568520 [No Abstract] [Full Text] [Related]
30. Multiple endocrine neoplasia type 2A in an Iranian family: clinical and genetic studies. Ghazi AA, Bagheri M, Tabibi A, Sarvghadi F, Abdi H, Hedayati M, Pourafkari M, Tirgari F, Yu R. Arch Iran Med; 2014 May 01; 17(5):378-82. PubMed ID: 24784869 [Abstract] [Full Text] [Related]
31. [Clinical features and mutations of RET proto-oncogene in a pedigree affected with type 2A multiple endocrine neoplasia]. Zhang Y, Zheng X, Cheng L, Ma S. Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2017 Feb 10; 34(1):106-109. PubMed ID: 28186607 [Abstract] [Full Text] [Related]
32. Multiple endocrine neoplasia type 2. Wohllk N, Schweizer H, Erlic Z, Schmid KW, Walz MK, Raue F, Neumann HP. Best Pract Res Clin Endocrinol Metab; 2010 Jun 10; 24(3):371-87. PubMed ID: 20833330 [Abstract] [Full Text] [Related]
33. Hereditary Medullary Thyroid Cancer Genotype-Phenotype Correlation. Frank-Raue K, Raue F. Recent Results Cancer Res; 2015 Jun 10; 204():139-56. PubMed ID: 26494387 [Abstract] [Full Text] [Related]
35. A 6-Base Pair in Frame Germline Deletion in Exon 7 Of RET Leads to Increased RET Phosphorylation, ERK Activation, and MEN2A. Latteyer S, Klein-Hitpass L, Khandanpour C, Zwanziger D, Poeppel TD, Schmid KW, Führer D, Moeller LC. J Clin Endocrinol Metab; 2016 Mar 10; 101(3):1016-22. PubMed ID: 26765577 [Abstract] [Full Text] [Related]
36. Multiple Endocrine Neoplasia Type 1, Type 2A, and Type 2B. Greenberg LA. Prim Care; 2024 Sep 10; 51(3):483-494. PubMed ID: 39067973 [Abstract] [Full Text] [Related]
37. Multiple endocrine neoplasia type 2. Lodish M. Front Horm Res; 2013 Sep 10; 41():16-29. PubMed ID: 23652668 [Abstract] [Full Text] [Related]
38. Bilateral pheochromocytoma during the postpartum period. Wattanachanya L, Bunworasate U, Plengpanich W, Houngngam N, Buranasupkajorn P, Sunthornyothin S, Shotelersuk V, Snabboon T. Arch Gynecol Obstet; 2009 Dec 10; 280(6):1055-8. PubMed ID: 19340440 [Abstract] [Full Text] [Related]
39. A MEN2A family with two asymptomatic carriers affected by unilateral renal agenesis. Hibi Y, Ohye T, Ogawa K, Shimizu Y, Shibata M, Kagawa C, Mizuno Y, Kurahashi H, Iwase K. Endocr J; 2014 Dec 10; 61(1):19-23. PubMed ID: 24152999 [Abstract] [Full Text] [Related]
40. Genotype-Phenotype Correlation in Indian Patients with MEN2-Associated Pheochromocytoma and Comparison of Clinico-Pathological Attributes with Apparently Sporadic Adrenal Pheochromocytoma. Rajan S, Zaidi G, Agarwal G, Mishra A, Agarwal A, Mishra SK, Bhatia E. World J Surg; 2016 Mar 10; 40(3):690-6. PubMed ID: 26438242 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]